about
Portuguese community pharmacists' attitudes to and knowledge of antibiotic misuse: questionnaire development and reliability.Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology.Antiviral drug resistance as an adaptive processDeterminants of antibiotic dispensing without a medical prescription: a cross-sectional study in the north of SpainPhysicians' attitudes and knowledge concerning antibiotic prescription and resistance: questionnaire development and reliability.Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.Effects of a computerized provider order entry and a clinical decision support system to improve cefazolin use in surgical prophylaxis: a cost saving analysis.Decreasing antibiotic use through a joint intervention targeting physicians and pharmacists.Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes.A prospective study of the use of antibiotics in the Emergency Department of a Chinese University Hospital.Observation of a Pharmacist-Conducted Group A Streptococcal Pharyngitis Point-of-Care Test: A Time and Motion Study.Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients.Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool.Attitudes of community pharmacists to antibiotic dispensing and microbial resistance: a qualitative study in Portugal.Rapid evolution meets invasive species control: the potential for pesticide resistance in sea lampreyAntimicrobial use by WHO methodology at primary health care centers: a cross sectional study in Punjab, Pakistan
P2860
Q31153419-71DEAF10-6A83-4BC6-A3BA-7704A72E547AQ33617774-088D3D43-FE8D-4DBD-9169-D3A077A65485Q33878407-1B517108-AA73-4B9A-BAC0-9DBF43B8A0EFQ34331032-34C6685C-59BD-4027-BD89-873BB383EBE7Q35889022-1EC51DC8-D63F-4F06-AC29-7466293D43C8Q36172235-2BD74258-55C6-4DF3-BBBF-3E691B4A3485Q37334513-73554E47-AE5E-42BB-90E0-27C0837049BBQ38390140-4FB363F4-CA88-4808-AF5B-1FC647CCD049Q38987535-574CFA7E-0F4C-4542-AB52-4EB25254C74EQ39015527-8516206B-0CD3-46C8-A105-A030926B14C0Q40195578-042CB6B3-B51D-49F0-A113-3637DA61C069Q40394708-FCE80428-F5FD-433E-8046-5EC749B504A7Q40587111-59F59FF7-8BFA-4EE6-AD03-6BCB99359EF6Q52802103-B26D98DA-277A-4113-A22D-0DEBA82C15D8Q57027095-A7EDF83C-849C-49C5-8AEC-4A7A332F40FFQ57945162-7747E98C-A435-4119-89A6-3EE6EA10B37E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The economic burden of drug resistance.
@ast
The economic burden of drug resistance.
@en
type
label
The economic burden of drug resistance.
@ast
The economic burden of drug resistance.
@en
prefLabel
The economic burden of drug resistance.
@ast
The economic burden of drug resistance.
@en
P356
P1476
The economic burden of drug resistance.
@en
P2093
David H Howard
R Douglas Scott
P304
P356
10.1086/430792
P407
P478
41 Suppl 4
P577
2005-08-01T00:00:00Z